These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27556459)

  • 1. Expression and Critical Role of Interleukin Enhancer Binding Factor 2 in Hepatocellular Carcinoma.
    Cheng S; Jiang X; Ding C; Du C; Owusu-Ansah KG; Weng X; Hu W; Peng C; Lv Z; Tong R; Xiao H; Xie H; Zhou L; Wu J; Zheng S
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27556459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRNDE-h transcript/miR-136-5p axis regulates interleukin enhancer binding factor 2 expression to promote hepatocellular carcinoma cell proliferation.
    Shiu TY; Lin HH; Shih YL; Feng AC; Huang HH; Huang TY; Hsieh CB; Chang WK; Hsieh TY
    Life Sci; 2021 Nov; 284():119708. PubMed ID: 34153299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine-Induced ILF2 Facilitates Nuclear mRNA Export of Pluripotency Factors to Promote Stemness and Chemoresistance in Human Esophageal Cancer.
    Li Y; Wang M; Yang M; Xiao Y; Jian Y; Shi D; Chen X; Ouyang Y; Kong L; Huang X; Bai J; Hu Y; Lin C; Song L
    Cancer Res; 2021 Jul; 81(13):3525-3538. PubMed ID: 33975879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DYNLL1 accelerates cell cycle via ILF2/CDK4 axis to promote hepatocellular carcinoma development and palbociclib sensitivity.
    Liu Y; Li Z; Zhang J; Liu W; Guan S; Zhan Y; Fang Y; Li Y; Deng H; Shen Z
    Br J Cancer; 2024 Jul; 131(2):243-257. PubMed ID: 38824222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ILF2 Directly Binds and Stabilizes CREB to Stimulate Malignant Phenotypes of Liver Cancer Cells.
    Du H; Le Y; Sun F; Li K; Xu Y
    Anal Cell Pathol (Amst); 2019; 2019():1575031. PubMed ID: 30881868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of B7-H4 suppresses tumor progression of hepatocellular carcinoma.
    Dong L; Xie L; Li M; Dai H; Wang X; Wang P; Zhang Q; Liu W; Hu X; Zhao M
    Sci Rep; 2019 Oct; 9(1):14854. PubMed ID: 31619714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA LEF1-AS1 silencing diminishes EZH2 expression to delay hepatocellular carcinoma development by impairing CEBPB-interaction with CDCA7.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    Cell Cycle; 2020 Apr; 19(8):870-883. PubMed ID: 32178558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
    Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
    Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cereblon Promotes the Ubiquitination and Proteasomal Degradation of Interleukin Enhancer-Binding Factor 2.
    Lian Q; Gao Y; Li Q; He X; Jiang X; Pu Z; Xu G
    Protein J; 2020 Oct; 39(5):411-421. PubMed ID: 33009960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SMAC mimetic birinapant inhibits hepatocellular carcinoma growth by activating the cIAP1/TRAF3 signaling pathway.
    Ding J; Qin D; Zhang Y; Li Q; Li Y; Li J
    Mol Med Rep; 2020 Mar; 21(3):1251-1257. PubMed ID: 31922244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/IDH2 axis.
    Xi Z; Huang H; Hu J; Yu Y; Ma X; Xu M; Ming J; Li L; Zhang H; Chen H; Huang T
    J Exp Clin Cancer Res; 2024 Jan; 43(1):22. PubMed ID: 38238853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
    Gao J; Dai C; Yu X; Yin XB; Zhou F
    J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma.
    Ye J; Liang R; Bai T; Lin Y; Mai R; Wei M; Ye X; Li L; Wu F
    J Exp Clin Cancer Res; 2018 Sep; 37(1):212. PubMed ID: 30176896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin enhancer-binding factor 2 promotes cell proliferation and DNA damage response in metastatic melanoma.
    Zhang X; Bustos MA; Gross R; Ramos RI; Takeshima TL; Mills GB; Yu Q; Hoon DSB
    Clin Transl Med; 2021 Oct; 11(10):e608. PubMed ID: 34709752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivo.
    Wei W; Li L; Wang X; Yan L; Cao W; Zhan Z; Zhang X; Yu H; Xie Y; Xiao Q
    Mol Med Rep; 2015 Jul; 12(1):905-12. PubMed ID: 25738600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
    Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
    Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory factor X5 promotes hepatocellular carcinoma progression by transactivating tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta and suppressing apoptosis.
    Chen DB; Zhao YJ; Wang XY; Liao WJ; Chen P; Deng KJ; Cong X; Fei R; Wu X; Shao QX; Wei L; Xie XW; Chen HS
    Chin Med J (Engl); 2019 Jul; 132(13):1572-1581. PubMed ID: 31188160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.